Document:

<PAGE>

                                                                   EXHIBIT 10.10

CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY
FILED HEREWITH OMITS THE INFORMATION SUBJECT TO THE CONFIDENTIALITY REQUEST.
OMISSIONS ARE DESIGNATED AS *. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED
SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

                      AMENDMENT NO. 2 TO LICENSE AGREEMENT

         THIS AMENDMENT TO LICENSE AGREEMENT ( "AMENDMENT") made as of the 8th
day of July, 2004, by and between ANORMED INC., a federal corporation
incorporated pursuant to the laws of Canada and having an office at 200 - 20353
64th Avenue, Langley, British Columbia, Canada V2Y 1N5 ("ANORMED") and SYNERGY
PHARMACEUTICALS INC., a Delaware corporation having an office at 7 Deer Park
Drive, Suite N, Monmouth Junction, NJ 08852 ("SYNERGY") and Callisto
Pharmaceuticals, Inc., a Delaware corporation having an office at 2500-420
Lexington Avenue, New York, NY 10170 ("Callisto").

                          W I T N E S S E T H   T H I S:

         WHEREAS:

A.       Pursuant to an agreement entitled "License Agreement" (the "LICENSE
         AGREEMENT") dated as of August 28th, 2002 and made between AnorMED and
         Synergy, AnorMED granted to Synergy a license to develop, manufacture,
         have manufactured, use and commercialize products incorporating
         Atiprimod (a/k/a Azaspiranes) upon the terms and conditions therein set
         forth;

B.       Pursuant to an agreement entitled "Amendment No. 1 to License
         Agreement" (the "FIRST AMENDING AGREEMENT") dated as of May 23rd, 2003
         and made between AnorMED and Synergy, the parties agreed to modify the
         terms of the License Agreement;

C.       Synergy is a wholly-owned subsidiary of Callisto; and

D.       The parties wish to further modify the terms of the License Agreement,
         as hereinafter provided.

              NOW, THEREFORE, in consideration of good and valuable
consideration, the mutual receipt and legal sufficiency of which are hereby
acknowledged, the parties agree as follows:

<PAGE>

              1. DEFINITIONS. All capitalized terms used and not otherwise
defined herein shall have the meanings ascribed to them in the License
Agreement. All references in the License Agreement to "this Agreement" shall be
deemed to be the License Agreement as amended by the First Amending Agreement
and this Agreement unless the context requires otherwise.

              2. AMENDMENT. Section 3 of the License Agreement is hereby amended
by adding the following sentence at the end of the last paragraph::

              "Notwithstanding the foregoing, in the event Synergy files the
              First Health Registration Application based on a Phase II study
              and prior to the completion of a Phase III study, the payment to
              AnorMED by Synergy of US$* (the "Payment") shall be deferred until
              the earlier of (i) the First Health Registration Approval, or (ii)
              the First Health Registration Application following the completion
              of a Phase III study, at which time the Payment shall be made
              within ninety (90) days following the First Health Registration
              Approval or the First Health Registration Application following
              the completion of a Phase III study, as the case may be."

              3. GUARANTEE. Callisto irrevocably guarantees to AnorMED the due
and punctual performance by Synergy of each and every obligation under the
License Agreement. The obligations of Callisto hereunder shall be absolute and
unconditional, shall not be subject to any counter-claim, set-off, deduction, or
abatement and shall remain in full force and effect without regard to, and shall
not be released, discharged or in any way affected by any circumstance or
condition other than the performance in full of the guaranteed obligation.

              4. CONTINUED FORCE AND EFFECT. The parties acknowledge and agree
that except as amended by the First Amending Agreement and this Amendment, the
License Agreement is and remains unchanged and in full force and effect.

              5. TIME OF THE ESSENCE. Time is expressly declared and stipulated
to be of the essence of this Amendment in respect of all payments to be made
hereunder and all covenants and agreements to be performed and fulfilled. Any
extension of time hereunder shall not be deemed to be or to operate in law as a
waiver that time is to be of the essence of this Amendment.

              6. COUNTERPARTS. This Amendment may be executed in any number of
counterparts, provided each of the parties hereto executes at least one
counterpart; each such counterpart hereof shall be deemed to be an original
instrument, and all such counterparts together shall constitute one agreement.

              7. GOVERNING LAW. This Amendment shall be construed and enforced
in accordance with the laws of the State of Washington, U.S.A. (regardless of
its or any other state's choice of law provisions)..

              8. FACSIMILE. This Amendment may be executed by facsimile, and
such signatures shall have the same force and effect as originals.

<PAGE>

         IN WITNESS WHEREOF, the parties have executed this Amendment as of the
day and year first above written.

                                       ANORMED INC.

                                       By: /s/ Gary J. Bridger, PhD
                                           --------------------------
                                               Name:  Gary J. Bridger, PhD
                                               Title: VP, Research &
                                                      Development
                                                      Chief Scientific Officer

                                       SYNERGY PHARMACEUTICALS INC.

                                       By: /s/ Gary S. Jacob
                                           --------------------------
                                               Name:  Gary S. Jacob
                                               Title: Chairman

                                       CALLISTO PHARMACEUTICALS, INC.

                                       By: /s/ Gary S. Jacob
                                           ---------------------------
                                               Name:  Gary S. Jacob
                                               Title: ChairmanKMR Exhibit 10.4 Resignation and Non-Compete Agreement

Exhibit 10.4

RESIGNATION AND NON-COMPETE AGREEMENT

     This Agreement ("Agreement") is entered
into this 21st day of July, 2004 between KMGP Services, Inc. (on behalf of itself and the
other persons and entities included in the definition of KM (as defined below), and Michael
C. Morgan ("Employee").

     WHEREAS, Employee is currently employed as an
at-will employee of KM;

     WHEREAS, Employee has decided to resign from his
position as President of Kinder Morgan, Inc. ("KMI"), Kinder Morgan G.P., Inc.,
Kinder Morgan Management, LLC and as an officer and director of their respective
affiliates in order to pursue other opportunities, including as a principal of Portcullis
Partners, L.P., while remaining an unpaid employee and retaining his membership on KMI's
Board of Directors (the "Board");

     WHEREAS, the parties wish to provide for certain
terms and conditions associated with this resignation;

     WHEREAS, the parties negotiated certain terms to
extend past employment, including, without limitation, terms relating non-competition and
confidentiality;

     WHEREAS, Employee agrees that ample consideration
was provided to ensure enforcement of such provisions;

     NOW THEREFORE, in consideration of the foregoing
premises and the following promises, the parties agree as follows:

          1.    Intent of the Parties. It is the
intent of the parties that all rights under any previous agreement(s) or understandings
concerning Employee's employment by KM shall be waived and forfeited upon execution of
this Agreement, except as described on Schedule 1 attached hereto.

          2.    Definitions.

               (a)   KM. "KM" as used in this Agreement
shall mean and include Kinder Morgan Energy Partners, L.P., Kinder Morgan, Inc., Kinder
Morgan Management, LLC and their respective divisions, subsidiaries, parents and/or
affiliates, successors or assigns, and, for purposes of this Agreement, the term
"affiliates" shall have the same definition as the term "affiliated
group" in Section 1504(a) of the Internal Revenue Code of 1986, as amended from time
to time.

               (b)   Confidential Information. "Confidential
Information" shall

include all information comprising, concerning or relating to (i) KM's Customers (as
defined below), providers, suppliers, and other business affiliates; (ii) KM's policies,
practices, operating information, pricing, profits, margins, costs, expenses, return
expectations, financial information, business plans, economic models and market
approaches; and (iii) other information, techniques or approaches used by KM and not
generally known or applied in KM's industry. KM believes that some or all of this
information constitutes trade secrets; however, the Confidential Information covered in
this Agreement need not satisfy the legal definition or requirements of a "trade
secret" to be protected from disclosure hereunder. Confidential Information shall not

 

include any information that is generally known in KM's industry and information
already known to any future employer of Employee through no fault of Employee, and any
information disclosed by KM in public filings including without limitation SEC or FERC
filings.

               (e)   Customer. "Customer" shall include
any person or entity to whom at any time during the Employment Period (as defined below)
services are being sold by KM, and any person or entity with which, at any time during the
Employment Period, KM has established a strategic marketing alliance.

               (f)   Effective Date. This Agreement shall be
effective upon execution hereof by both parties.

          3.    Resignation. Employee hereby
resigns his position as an officer and director of each entity included in KM, other than
his position as a director of KMI.

          4.    KM's Promises. In consideration
of Employee's performance hereunder:

               (a)   Bonus. Employee will be eligible for a 2004
annual incentive bonus under the terms of the KM bonus program. All Bonus Payments shall
be subject to applicable required withholdings. Employee shall not be eligible for an
annual incentive bonus for any periods flowing calendar year 2004.

               (b)   Medical Benefits. KM agrees to provide best
efforts to allow Employee to participate, at Employee's cost, in those health benefit
plans that active employees are eligible to participate in to the extent permissible by
applicable law and subject to the terms and conditions of the applicable plan(s).

               (c)   Restricted Stock. In consideration for
Employee's promises set forth in Section 5 below (but not in consideration for Employee's
service as a director of KMI) and subject to Section 6 below, Employee shall continue to
hold 23,333 shares of restricted stock of KMI (as described on Schedule 1 attached hereto)
on the same terms and conditions as are set forth in that certain Restricted Stock
Agreement (the "July 16, 2003 Grant"), dated July 16, 2003, between Employee and
KMI; provided that (i) 8,333 shares shall vest and cease to be subject to forfeiture
restrictions on July 16, 2006 and 15,000 shares shall vest on July 16, 2008; (ii) 76,667
shares subject to the July 16, 2003 Grant shall be forfeited; and (iii) to the extent the
approval of the shareholders of KMI is not necessary for Employee to continue to hold such
23,333 shares or to cancel the July 16, 2003 Grant and issue Employee a new grant of
23,333 shares of restricted stock of KMI, KM may substitute cash payments in lieu of the
value of the restricted stock and the dividends paid thereon. Such payments shall be made
(x) on July 16, 2006 and July 16, 2008 in the case of the value of the shares of
restricted stock and (y) on the date(s) KMI pays dividends to its shareholders in the case
of dividends.

          5.    Employee's Promises. Employee
acknowledges and agrees that; 1) KM and its affiliates are engaged in, among other things,
owning and/or operating integrated natural gas assets, products, chemicals and bulk
terminals, refined products, natural gas, natural gas liquids and carbon dioxide
pipelines, electricity generating assets, crude oil production assets and other midstream
energy assets; (the "Business"); 2) the Business is conducted throughout the

2

United States; 3) his work for KM gave and will continue (during the Employment Period)
to give him access to Confidential Information, proprietary information and trade secrets
of and concerning KM, KM's actual and potential Customers, providers, suppliers, and other
business affiliates; 4) his work for KM gave and will continue (during the Employment
Period) to give him access to KM's actual and potential Customers, providers, suppliers,
and other business affiliates with whom KM has expended substantial efforts to
successfully establish goodwill; and 4) the agreements and covenants contained in this
Paragraph 4 are essential to protect the Business and the trade secrets, Confidential
Information, proprietary information, goodwill and other legitimate interests of KM.
Accordingly, Employee agrees and covenants as follows:

               (a)   Confidential Information. Employee agrees and
covenants that he shall not at any time, directly or indirectly, (i) use or apply any
Confidential Information for any purpose not expressly authorized by an officer of KM,
alone or with any other person or entity; or (ii) disclose or provide any Confidential
Information to any person or entity not expressly authorized by an officer of KM to
receive such Confidential Information provided, however, that Employee shall not be held
in breach of this provision should Employee be required to testify pursuant to subpoena
under oath or as otherwise required by law, provided additionally that Employee testifies
truthfully and that, prior to providing such testimony, Employee notifies KM within 48
hours that his testimony is being sought so as to permit KM to seek to prevent or limit
such testimony or otherwise seek to obtain a protective order.

               (b)   Non-Disparagement Agreement. Employee agrees
and covenants that he will not in any way knowingly disparage KM, its officers, directors,
employees, consultants, agents, or business performance, methods, practices, operations,
decisions or plans; provided, however, that Employee shall not be held in breach of this
provision should Employee be required to testify pursuant to subpoena under oath or as
otherwise required by law, provided additionally that Employee testifies truthfully and
that, prior to providing such testimony, Employee notifies KM within 48 hours that his
testimony is being sought so as to permit KM to seek to prevent or limit such testimony or
otherwise seek to obtain a protective order. KM likewise agrees not to disparage Employee,
in the same manner and subject to the same limitations set forth in this Section 5(b).

               (c)   Non-Solicitation of KM Employees. Employee
agrees and covenants that prior to the earlier of (i) July 21, 2008 or (ii) for one (1)
years following the date of termination of Employee's membership on the Board for any
reason whatsoever, he will not hire, encourage, entice, or otherwise solicit any employee
of KM, or aid any third party to hire, encourage, entice or solicit any employee of KM, to
leave employment with KM in order to accept employment elsewhere. For purposes of this
paragraph, "employment elsewhere" shall include any relationship of
employer/employee, any relationship of principal/independent contractor and any
relationship of client/consultant.

               (d)   Non-Competition. Employee agrees and covenants
that prior to the earlier of (i) July 21, 2008 or (ii) one (1) years following the date of
termination of Employee's membership on the Board for any reason whatsoever, Employee will
not, directly or indirectly, engage or become interested, as employee, owner, consultant,
advisor, officer, director or partner, or through stock ownership, investment of capital,
lending of money or property, or rendering of services or otherwise, either alone or in
association with others, in any type of business or enterprise which is in competition
with or which is directly or indirectly 

3

detrimental to KM's Business, provided, however, that the record or beneficial
ownership by Employee of one percent (1%) or less of the outstanding publicly traded
capital stock of any such business or enterprise shall not be deemed to be in violation of
this Paragraph 5(d), provided further that Employee is not an employee, consultant,
advisor, officer, director or partner of such business or enterprise.

               (e)   Confidentiality of this Agreement. KM and
Employee agree not to divulge, disclose or publicize in any manner to any third party,
including but not limited to current or former employees of KM, the existence or terms and
conditions of this Agreement, except, with respect to disclosure by Employee: (1) insofar
as is necessary to enforce the Agreement, comply with this Agreement, applicable laws or
regulations, or to respond to an order of a court or administrative agency for disclosure,
(2) to Employee's legal counsel, spouse, or tax or financial advisors, on condition that
any such person to whom the terms or conditions of this Agreement are disclosed shall be
instructed not to disclose the terms or conditions to anyone else; and with respect to
disclosure by KM: (1) insofar as is necessary to enforce the Agreement, comply with this
Agreement, applicable laws or regulations, or to respond to an order of a court or
administrative agency for disclosure, (2) to KM's legal counsel, KM's directors and
officers, and KM's internal human resources and accounting personnel and auditors (only to
the extent necessary for reporting purposes), on condition that any such person to whom
the terms or conditions of this Agreement are disclosed shall be instructed not to
disclose the terms or conditions to anyone else.

               (f)   Employee acknowledges and agrees that any
breach by him of the covenants, commitments and agreements in Paragraph 5 of this
Agreement shall constitute a material breach of this Agreement and is likely to result in
irreparable injury to KM that could not be compensated by money damages alone. Employee
therefore agrees that, notwithstanding any other provision of this Agreement, in addition
to any other remedies KM may have at law and/or equity, in the event that KM determines
that Employee has breached any of said provisions of this Agreement, KM shall be entitled,
at its election, to immediately stop making any payments hereunder and/or to terminate the
vesting of, or otherwise cancel or terminate, the unvested portion of the restricted stock
referenced in Section 4(c) hereof and/or to enforce the specific performance of this
Agreement by Employee and/or to seek to enjoin Employee from activities in breach of said
provisions of this Agreement without having to show that there are no other adequate
remedies available, whether such breach of said provisions occurs during the Employment
Period or thereafter. KM acknowledges and agrees that, without limiting the remedies set
forth above, its sole remedy with respect to monetary damages shall be forfeiture of
unvested restricted stock described in Section 4(c) hereof.

               (g)   The parties stipulate and agree that the
terms, covenants, commitments and agreements contained in this Paragraph 5 are fair and
reasonable in all respects, and that these restrictions are necessary for the reasonable
protection of the legitimate business interests of KM. If, at the time of enforcement of
any of these provisions, a court holds that the restrictions stated herein are
unreasonable under the circumstances then existing, the parties hereto agree that the
maximum period, scope or geographical area reasonable under such circumstances will be
substituted for the stated period, scope or area. In such event, but only in such event,
the parties hereto hereby specifically request a trial court or other tribunal presented
with this Agreement for enforcement to reform it as to time, geographic area or scope of 

4

activities prohibited to the fullest extent allowed by law and to enforce this
Agreement as so reformed.

               (h)   Employee shall have the right to request in a
special exception to Section 5 of this Agreement. Such request shall be in writing,
directed to KM's General Counsel, and shall clearly and specifically identify the
exemption sought and the bases therefore. KM shall have thirty (30) business days to
respond to such written request for a special exception. If, after a timely review, KMI
determines in its sole discretion that no significant issues exist regarding the
protection of its trade secrets, proprietary information and/or Confidential Information,
the preservation of its goodwill, or a conflict of interest, KMI shall not withhold the
granting in writing of said special exception. In the event that KM does not respond to a
request for a special exception with the thirty day period described above, KM shall be
deemed to have granted the request for special exception. KMI's decision to grant a
special exception (or failure to respond to a response therefore) shall not be considered
to be a waiver of the provisions of Section 5 except as to the specific activities on
behalf of the specific entity for which Employee sought such waiver.

          6.    Payment Conditions. In the event
that KM determines that Employee has breached any of the provisions of Paragraph 5 of this
Agreement, KM shall be entitled to immediately stop making any payments of any type under
Paragraph 4(c) of this Agreement and/or to terminate the vesting or exercisability of
23,333 shares of restricted stock reference in Section 5 hereof (to the extent vesting has
not occurred at the time of breach), or to require that Employee's stock option grant of
October 9, 1999 shall expire on the thirtieth day after KM provides Employee notice of
such breach.

          7.    Adequacy of Consideration. By
executing this Agreement, KM and Employee acknowledges the receipt and sufficiency of the
consideration provided by the other in conjunction with executing this Agreement and the
Further Release. Each acknowledges and confirms to the other that the consideration
provided by the other is good and valuable consideration legally supportive of each
party's respective rights, duties and obligations hereunder and under the Further Release.
By executing this Agreement, KM and Employee shall be estopped from raising and hereby
expressly waive any defense regarding the receipt and/or legal sufficiency of the
consideration provided by one to the other with respect to this Agreement and the Further
Release.

          8.    Assignability. This Agreement
shall inure to the benefit of, and be binding upon, Employee and Employee's personal or
legal representatives, employees, administrators, successors, heirs, distributees,
devisees and legatees, and KM, its successors and assignees, provided, however, that
neither KM nor Employee may assign any of Employee's or its obligations, rights or
benefits hereunder without the prior written consent of the other.

          9.    Headings. The headings of
sections and paragraphs herein are included solely for convenience of reference and shall
not control the meaning or interpretation of any of the provisions of this Agreement.

          10.   Controlling Law. This Agreement shall
be governed and construed in accordance with the laws of Texas. The parties agree that any
legal action regarding this Agreement must be filed in the state of Texas.

5

          11.   Entire Agreement. This document
constitutes the entire agreement of the parties on the subject matters addressed herein
and may not be expanded or except by express written agreement executed by both.

          12.   Counterparts. This Agreement may be
executed in as many counterparts as may be deemed necessary and convenient, and by the
different parties on separate counterparts, each of which shall be deemed an original but
all of which shall constitute one and the same instrument.

[Remainder of page intentionally left blank - signature page to follow]

 

 

6

 

	  	KMGP SERVICES, INC.

    KINDER MORGAN ENERGY PARTNERS, L.P.

    KINDER MORGAN, INC.

    KINDER MORGAN MANAGEMENT, LLC

    (each on its own behalf and on behalf

    of the other persons or entities included

    within the definition of KM)  
		  

      

	By:	  
	Title:	  

		  

      		
	  	EMPLOYEE	  	
		  		
		  		
		  		  
		Michael C. Morgan		Date

 

 

7

Exhibit A

FURTHER RELEASE

     For good and valuable consideration set forth in
Paragraph 3 of the Retention and Non-Competition Agreement of which this Exhibit is a part
(the "Agreement"), the receipt and sufficiency of which is hereby acknowledged,
Michael C. Morgan ("Morgan") and KM (as defined in the Agreement) hereby agree
as follows:

1.    General
Release. Morgan, for himself and his representatives, heirs, and assigns, hereby
releases and forever discharges KM, and any present or former parent, sister, affiliate or
subsidiary company, partnership, limited partnership or entity, and each of its and their
shareholders, unit holders, partners, general partners, limited partners, officers,
directors, employees, agents, representatives, legal representatives, accountants,
successors, predecessors, and assigns (the "KM Releasees"), from all claims,
demands, and actions of any nature, known or unknown, which Morgan may have against the KM
Releasees as of the Effective Date of this Further Release, and specifically, but not
limited to, any and all claims, known or unknown, in any manner arising out of or
involving any aspect of his employment with any of the KM Releasees, and including, but
not limited to, any rights or claims under the Texas Anti-Discrimination Act, the Age
Discrimination in Employment Act ("ADEA"); Title VII of the Civil Rights Act of
1964; the Vocational Rehabilitation Act; the Americans with Disabilities Act; Executive
Order 11246; the Civil Rights Act of 1871; the National Labor Relations Act; the Worker
Adjustment and Retraining Notification Act; the Employee Retirement Income Security Act of
1974; the Equal Pay Act (all as may have been or may be amended from time to time); and
any and all other municipal, state, and/or federal statutory, executive order, or
constitutional provisions pertaining to employment, an employment relationship, sexual
harassment and/or employee benefits; provided, however, that this release and waiver shall
not apply to any rights which, by law, may not be waived, or any rights expressly set
forth in the Agreement. This release and waiver also specifically includes, but is not
limited to, any known or unknown claims in the nature of tort, statutory law, common law
or contract claims, including specifically but not limited to any claim of wrongful
refusal to hire, wrongful discharge, retaliatory discharge, unpaid wages, unpaid vacation,
unpaid bonuses, unvested stock or stock options, unpaid benefits, intentional or negligent
infliction of emotional distress, defamation, or other such claims in any manner arising
out of or involving any aspect of Morgan's employment, the terms and conditions of such
employment, or termination of employment with KM. This release also includes, without
limitation, any and all known or unknown claims concerning attorney fees, costs, and any
and all other expenses related to the claims released herein.

2.     ADEA
Release. By executing this Further Release, Morgan knowingly and voluntarily waives
any and all claims under the Age Discrimination in Employment Act ("ADEA"), and
further agrees with respect to the ADEA that:

	     (a)  
	This waiver is part of an Agreement that
    is written in a manner that he understands.

	  
	
	     (b)  
	This waiver specifically refers to rights
    and claims arising under the ADEA.

 

	  	
	     (c)  
	Morgan does not waive any claims under the
    ADEA that may arise after the date that he executes this Further Release.

	  
	
	     (d)  
	Morgan waives ADEA rights or claims.

	  
	
	     (e)  
	Morgan has had an opportunity to consult
    with an attorney before executing this Further Release insofar as it relates to waiver of
    claims under the ADEA and has been urged to do so.

	  
	
	     (f)  
	Morgan has been afforded a minimum of 21
    days from the date he received the Further Release within which to consider this Further
    Release insofar as it relates to claims under the ADEA.

	  	
	     (g)  
	Morgan shall have 7 days from the date he accepts and signs
    this Further Release within which to revoke his acceptance of this Further Release. To be
    effective, such revocation must be made in writing and delivered to the Executive Vice
    President Human Resources and Administration, Kinder Morgan, One Allen Center, 500 Dallas
    Suite 1000, Houston TX 77002, on or before the seventh (7th) day after Morgan
    signs it. If Morgan revokes this Further Release it shall not be effective or enforceable
    and he shall not receive the additional consideration set forth in Paragraph 4 of the
    Retention and Non-Compete Agreement that has not yet been paid to Morgan.
	  
	
	     (h)  
	This Further Release shall become effective immediately upon
    the eighth (8th) day after Morgan signs this Further Release, assuming such
    Further Release is not revoked as provided in Paragraph 2(g) above.
	  	  

      

	Date:	  	  	  
				Michael C. Morgan

 

 

2

SCHEDULE 1

	Restricted stock granted on January 17, 2000 and January 16, 2001 shall
    not be affected in any way by this agreement.Stock Option Agreements, dated April 20,
    2000, and October 9, 1999, shall not be affected in any way by this agreement.

    Restricted Stock Agreement, dated July 16, 2003, shall be amended to provide that 8,333
    shares shall vest on July 16, 2006 and 15,000 shares shall vest on July 16, 2008. All
    other shares subject to that agreement shall be forfeited. The remaining terms and
    conditions of the Restricted Stock Agreement shall apply with respect to the 23,333 shares
    that are not forfeited in connection with this Agreement.

 

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00069-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00069-of-00352.parquet"}]]